These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12848817)

  • 21. Effects of selective autonomic blockade on T-wave alternans in humans.
    Rashba EJ; Cooklin M; MacMurdy K; Kavesh N; Kirk M; Sarang S; Peters RW; Shorofsky SR; Gold MR
    Circulation; 2002 Feb; 105(7):837-42. PubMed ID: 11854124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis.
    Volders PG
    Heart Rhythm; 2010 Dec; 7(12):1900-6. PubMed ID: 20570754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural mechanisms involved in the regulation of ventricular repolarization.
    Abildskov JA
    Eur Heart J; 1985 Nov; 6 Suppl D():31-9. PubMed ID: 2417852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Brain-Heart Connection in Sympathetically Triggered Inherited Arrhythmia Syndromes.
    Winbo A; Paterson DJ
    Heart Lung Circ; 2020 Apr; 29(4):529-537. PubMed ID: 31959550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure.
    Leier CV; Binkley PF; Cody RJ
    Circulation; 1990 Aug; 82(2 Suppl):I68-76. PubMed ID: 2164897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot.
    Daliento L; Folino AF; Menti L; Zanco P; Baratella MC; Dalla Volta S
    J Am Coll Cardiol; 2001 Dec; 38(7):2043-7. PubMed ID: 11738313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular repolarization: an overview of (patho)physiology, sympathetic effects and genetic aspects.
    Conrath CE; Opthof T
    Prog Biophys Mol Biol; 2006 Nov; 92(3):269-307. PubMed ID: 16023179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin receptors in the brain modulate autonomic responses and arrhythmogenesis during acute myocardial infarction in rats.
    Lekkas P; Kontonika M; Georgiou ES; La Rocca V; Mouchtouri ET; Mourouzis I; Pantos C; Kolettis TM
    Life Sci; 2019 Dec; 239():117062. PubMed ID: 31734261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis.
    Janse MJ
    Cardiovasc Res; 2004 Feb; 61(2):208-17. PubMed ID: 14736537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.
    Shimizu W; Tanabe Y; Aiba T; Inagaki M; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(12):1984-91. PubMed ID: 12084597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for treatment of patients with chronic heart failure with adrenergic blockade.
    Sackner-Bernstein JD; Mancini DM
    JAMA; 1995 Nov; 274(18):1462-7. PubMed ID: 7474194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.